Oncotelic to present at the 2025 San Antonio Breast Cancer Symposium (SABCS) Highlighting Sapu003 (Deciparticle™ Everolimus)

Accepted Presentations Showcase First-in-Human Development, Manufacturing Innovation, and Predictive Biomarkers for Deciparticle™ Everolimus ...
Pulmonology Advisor

Ensifentrine May Improve Lung Function in COPD With and Without Exacerbations

Ensifentrine significantly improved lung function after 12 weeks in patients with moderate to severe COPD with and without ...
TipRanks on MSN

NuCana presents data at ESMO 2025 for NUC-7738, PD-1 inhibitors

NuCana (NCNA) presented data at the European Society for Medical Oncology Congress 2025, ESMO, on a new model system investigating the synergistic ...
Santé log

Oncotelic to Present at the LD Micro Main Event XIX

Event: LD Micro Main Event XIX Date: Tuesday, October 21st Time: 11:30 ...
Medscape

Novel Drug With New Mechanism Promising for Parkinson’s Motor Fluctuations

Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...

Experimental inhibitor reduces cell death in models of life-threatening skin reactions

A collaborative research group has developed a novel therapeutic candidate that may improve the prognosis of severe cutaneous ...
Science Daily

Doctors just found a way to slow one of the deadliest prostate cancers

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...
Le Lézard

Emphysema Market Analysis Reveals Promising Growth Opportunities and Trends During the Forecast Period (2025-2034) | DelveInsight

DelveInsight's Emphysema Market Insights report includes a comprehensive understanding of current treatment practices, emphysema emerging drugs, market share of individual therapies, and current and ...